Exam Bundle

Repeated worker imports no longer trigger unintended data writes would demonstrate the separate action Refactor import-time code into explicitly called initialization, which addresses “A package import creates unexpected side effects each time a worker loads it.” It does not verify the requirement “A task fails only on serverless compute because an unsupported native extension is required” following Select supported compatible compute or replace the incompatible dependency.

That observation is a valid indicator for “A wheel was built for a different Python version than the job runtime” when using Build a compatible distribution or update runtime within supported constraints. The scenario instead tests “A task fails only on serverless compute because an unsupported native extension is required”; the relevant result is The task runs successfully in its documented supported environment.

This signal belongs to the adjacent case “An external library is available to the notebook author but not to scheduled tasks,” whose remedy is Declare it as a task or bundle environment dependency. The observed result for the present requirement is The task runs successfully in its documented supported environment.

Add an approval step in the CI/CD pipeline before running the production deploy is appropriate when “A deployment requires a human approval boundary for regulated production”; it would be verified by The deploy cannot start until authorized approval is recorded. It does not directly satisfy “Operations need to know exactly which code and settings produced each pipeline run,” whose relevant acceptance evidence is Run evidence references the approved code revision and deployment target.

This action solves a different issue: “Production and development deployments should never share stateful checkpoints.” Its normal signal is Each environment advances its own independent processing state. Here the requested behavior is “Operations need to know exactly which code and settings produced each pipeline run,” so that signal is not sufficient.

This action solves a different issue: “A candidate release should be rejected if an integration test fails.” Its normal signal is An intentionally failing test prevents the deploy action. Here the requested behavior is “Operations need to know exactly which code and settings produced each pipeline run,” so that signal is not sufficient.

New runs use the previous code version while bad data is handled explicitly would demonstrate the separate action Redeploy the previously validated artifact and repair affected data separately, which addresses “A release introduced bad schema output and must be reverted quickly.” It does not verify the requirement “Operations need to know exactly which code and settings produced each pipeline run” following Record bundle revision, Git commit and target configuration in release metadata.

An intentionally failing test prevents the deploy action would demonstrate the separate action Gate production deployment on CI test outcomes, which addresses “A candidate release should be rejected if an integration test fails.” It does not verify the requirement “Operations need to know exactly which code and settings produced each pipeline run” following Record bundle revision, Git commit and target configuration in release metadata.

The deploy cannot start until authorized approval is recorded would demonstrate the separate action Add an approval step in the CI/CD pipeline before running the production deploy, which addresses “A deployment requires a human approval boundary for regulated production.” It does not verify the requirement “Operations need to know exactly which code and settings produced each pipeline run” following Record bundle revision, Git commit and target configuration in release metadata.

The alternative Add an approval step in the CI/CD pipeline before running the production deploy has a distinct purpose—A deployment requires a human approval boundary for regulated production. It would not establish the required outcome (A release introduced bad schema output and must be reverted quickly); the necessary verification concerns New runs use the previous code version while bad data is handled explicitly.

Use separate target-specific source, target and checkpoint paths belongs to the separate case “Production and development deployments should never share stateful checkpoints,” where Each environment advances its own independent processing state would be expected. That differs from the condition in this stem: “A release introduced bad schema output and must be reverted quickly.”

The alternative Gate production deployment on CI test outcomes has a distinct purpose—A candidate release should be rejected if an integration test fails. It would not establish the required outcome (A release introduced bad schema output and must be reverted quickly); the necessary verification concerns New runs use the previous code version while bad data is handled explicitly.

This signal belongs to the adjacent case “Production and development deployments should never share stateful checkpoints,” whose remedy is Use separate target-specific source, target and checkpoint paths. The observed result for the present requirement is New runs use the previous code version while bad data is handled explicitly.

The deploy cannot start until authorized approval is recorded would demonstrate the separate action Add an approval step in the CI/CD pipeline before running the production deploy, which addresses “A deployment requires a human approval boundary for regulated production.” It does not verify the requirement “A release introduced bad schema output and must be reverted quickly” following Redeploy the previously validated artifact and repair affected data separately.

This signal belongs to the adjacent case “A candidate release should be rejected if an integration test fails,” whose remedy is Gate production deployment on CI test outcomes. The observed result for the present requirement is New runs use the previous code version while bad data is handled explicitly.

This action solves a different issue: “A release introduced bad schema output and must be reverted quickly.” Its normal signal is New runs use the previous code version while bad data is handled explicitly. Here the requested behavior is “Production and development deployments should never share stateful checkpoints,” so that signal is not sufficient.

Gate production deployment on CI test outcomes is appropriate when “A candidate release should be rejected if an integration test fails”; it would be verified by An intentionally failing test prevents the deploy action. It does not directly satisfy “Production and development deployments should never share stateful checkpoints,” whose relevant acceptance evidence is Each environment advances its own independent processing state.

Add an approval step in the CI/CD pipeline before running the production deploy is appropriate when “A deployment requires a human approval boundary for regulated production”; it would be verified by The deploy cannot start until authorized approval is recorded. It does not directly satisfy “Production and development deployments should never share stateful checkpoints,” whose relevant acceptance evidence is Each environment advances its own independent processing state.

This signal belongs to the adjacent case “A deployment requires a human approval boundary for regulated production,” whose remedy is Add an approval step in the CI/CD pipeline before running the production deploy. The observed result for the present requirement is Each environment advances its own independent processing state.

That observation is a valid indicator for “A candidate release should be rejected if an integration test fails” when using Gate production deployment on CI test outcomes. The scenario instead tests “Production and development deployments should never share stateful checkpoints”; the relevant result is Each environment advances its own independent processing state.

Run evidence references the approved code revision and deployment target pertains to a different control (Record bundle revision, Git commit and target configuration in release metadata) and a different need (Operations need to know exactly which code and settings produced each pipeline run). It cannot establish that Use separate target-specific source, target and checkpoint paths met the stated goal.

Redeploy the previously validated artifact and repair affected data separately belongs to the separate case “A release introduced bad schema output and must be reverted quickly,” where New runs use the previous code version while bad data is handled explicitly would be expected. That differs from the condition in this stem: “A candidate release should be rejected if an integration test fails.”

Record bundle revision, Git commit and target configuration in release metadata belongs to the separate case “Operations need to know exactly which code and settings produced each pipeline run,” where Run evidence references the approved code revision and deployment target would be expected. That differs from the condition in this stem: “A candidate release should be rejected if an integration test fails.”

This action solves a different issue: “Production and development deployments should never share stateful checkpoints.” Its normal signal is Each environment advances its own independent processing state. Here the requested behavior is “A candidate release should be rejected if an integration test fails,” so that signal is not sufficient.

Each environment advances its own independent processing state pertains to a different control (Use separate target-specific source, target and checkpoint paths) and a different need (Production and development deployments should never share stateful checkpoints). It cannot establish that Gate production deployment on CI test outcomes met the stated goal.

The deploy cannot start until authorized approval is recorded pertains to a different control (Add an approval step in the CI/CD pipeline before running the production deploy) and a different need (A deployment requires a human approval boundary for regulated production). It cannot establish that Gate production deployment on CI test outcomes met the stated goal.

This signal belongs to the adjacent case “A release introduced bad schema output and must be reverted quickly,” whose remedy is Redeploy the previously validated artifact and repair affected data separately. The observed result for the present requirement is An intentionally failing test prevents the deploy action.

Redeploy the previously validated artifact and repair affected data separately is appropriate when “A release introduced bad schema output and must be reverted quickly”; it would be verified by New runs use the previous code version while bad data is handled explicitly. It does not directly satisfy “A deployment requires a human approval boundary for regulated production,” whose relevant acceptance evidence is The deploy cannot start until authorized approval is recorded.

Record bundle revision, Git commit and target configuration in release metadata is appropriate when “Operations need to know exactly which code and settings produced each pipeline run”; it would be verified by Run evidence references the approved code revision and deployment target. It does not directly satisfy “A deployment requires a human approval boundary for regulated production,” whose relevant acceptance evidence is The deploy cannot start until authorized approval is recorded.

The alternative Use separate target-specific source, target and checkpoint paths has a distinct purpose—Production and development deployments should never share stateful checkpoints. It would not establish the required outcome (A deployment requires a human approval boundary for regulated production); the necessary verification concerns The deploy cannot start until authorized approval is recorded.

That observation is a valid indicator for “Production and development deployments should never share stateful checkpoints” when using Use separate target-specific source, target and checkpoint paths. The scenario instead tests “A deployment requires a human approval boundary for regulated production”; the relevant result is The deploy cannot start until authorized approval is recorded.

Run evidence references the approved code revision and deployment target pertains to a different control (Record bundle revision, Git commit and target configuration in release metadata) and a different need (Operations need to know exactly which code and settings produced each pipeline run). It cannot establish that Add an approval step in the CI/CD pipeline before running the production deploy met the stated goal.

That observation is a valid indicator for “A candidate release should be rejected if an integration test fails” when using Gate production deployment on CI test outcomes. The scenario instead tests “A deployment requires a human approval boundary for regulated production”; the relevant result is The deploy cannot start until authorized approval is recorded.